These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15693731)

  • 1. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.
    Secnik K; Swensen A; Lage MJ
    Pharmacoeconomics; 2005; 23(1):93-102. PubMed ID: 15693731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
    Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
    Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
    Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
    Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of bipolar disorder in an employed population from an employer perspective.
    Gardner HH; Kleinman NL; Brook RA; Rajagopalan K; Brizee TJ; Smeeding JE
    J Clin Psychiatry; 2006 Aug; 67(8):1209-18. PubMed ID: 16965198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age- and Gender-specific Costs as Well as Drug Therapies of ADHD Patients].
    Klora M; Zeidler J; Lublow D; Linder R; Verheyen F; von der Schulenburg JM
    Gesundheitswesen; 2016 Jul; 78(7):e23-9. PubMed ID: 26695543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD.
    Kawatkar AA; Knight TK; Moss RA; Sikirica V; Chu LH; Hodgkins P; Haim Erder M; Nichol MB
    Value Health; 2014 Sep; 17(6):661-8. PubMed ID: 25236989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm.
    Kessler RC; Lane M; Stang PE; Van Brunt DL
    Psychol Med; 2009 Jan; 39(1):137-47. PubMed ID: 18423074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace.
    Kleinman N; Abouzaid S; Andersen L; Wang Z; Powers A
    J Occup Environ Med; 2014 Feb; 56(2):161-70. PubMed ID: 24451611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany.
    Braun S; Russo L; Zeidler J; Linder R; Hodgkins P
    Clin Ther; 2013 May; 35(5):673-85. PubMed ID: 23587606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of illness and health care resource utilization in adult psychiatric outpatients with attention-deficit/hyperactivity disorder in Europe.
    Karlsdotter K; Bushe C; Hakkaart L; Sobanski E; Kan CC; Lebrec J; Kraemer S; Dieteren NA; Deberdt W
    Curr Med Res Opin; 2016 Sep; 32(9):1547-56. PubMed ID: 27171913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease burden and direct medical costs of incident adult ADHD: A retrospective longitudinal analysis based on German statutory health insurance claims data.
    Libutzki B; May M; Gleitz M; Karus M; Neukirch B; Hartman CA; Reif A
    Eur Psychiatry; 2020 Oct; 63(1):e86. PubMed ID: 32998793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.
    Leibson CL; Katusic SK; Barbaresi WJ; Ransom J; O'Brien PC
    JAMA; 2001 Jan; 285(1):60-6. PubMed ID: 11150110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between employee obesity and employer costs: evidence from a panel of U.S. employers.
    Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D
    Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson TM; Xie J; Erder MH; Dammerman RS; Robertson B; Wu EQ
    Am J Manag Care; 2014 Sep; 20(9):711-21. PubMed ID: 25365746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
    Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis.
    Hodgkins P; Montejano L; Sasané R; Huse D
    Prim Care Companion CNS Disord; 2011; 13(2):. PubMed ID: 21977356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.